EDIT
Editas Medicine Inc
2.60$
-6.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.7% | -24.1% | +354.1% | +102.8% | -41.6% | +7.1% | +87.7% | +96.9% | -57.9% | -66.2% | +12.6% | +65.2% | +219.2% | -53.4% | +87.8% | +484.6% | -81.8% | -43.1% | -94.2% | +1,535.1% | +101.2% | -45.7% | -6.0% | -99.3% | +15,461.9% | +50.7% | -70.7% | +84.8% | +1,025.4% | -98.1% | -54.8% | -88.1% | +50,070.5% | -84.8% | -23.2% | +110.8% | +228.0% | -88.6% | +320.0% | – | |
| – | +147.7% | -29.1% | -9.0% | +17.8% | +29.6% | -19.4% | +53.6% | -46.7% | +87.6% | -51.6% | +48.8% | -3.7% | +53.2% | -0.6% | -19.0% | +21.1% | +81.3% | -31.8% | -19.5% | -13.3% | +28.3% | +1.1% | +15.0% | -5.3% | +25.8% | -27.3% | -21.2% | -94.9% | -3.2% | -3.9% | +0.8% | +12.6% | +2,940.1% | -45.3% | -39.2% | +22.2% | -95.9% | -40.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -273.2% | – | – | – | – | – | – | – | – | – | – | – | +1,432.8% | -100.5% | – | – | – | – | – | – | – | -90.5% | +406.4% | – | |
| – | +147.7% | -29.1% | -9.0% | +17.8% | +29.6% | -19.4% | +53.6% | -46.7% | +10.0% | -17.5% | +48.8% | -3.7% | +53.2% | -0.6% | -19.0% | +21.1% | +81.3% | -31.8% | -19.5% | -13.3% | +28.3% | +1.1% | +15.0% | -5.3% | +25.8% | -27.3% | -21.2% | -82.1% | +1,176.0% | -30.4% | +11.4% | -9.8% | +2.0% | -45.3% | -39.2% | +22.2% | +38.6% | -89.7% | +612.8% | – | |
| – | +15.5% | -5.8% | -3.2% | +6.2% | +8.3% | +3.7% | +0.9% | -6.8% | -1.2% | +32.7% | -17.6% | +9.2% | +7.5% | +5.0% | -20.8% | +41.6% | -20.8% | +35.8% | +2.7% | -26.5% | +2.1% | +18.3% | -13.3% | -4.1% | +10.8% | +27.9% | -25.2% | -12.9% | -3.5% | +33.8% | -5.9% | -0.6% | -9.6% | -18.2% | -3.9% | -4.2% | -7.8% | -9.9% | +13.4% | – | |
| – | +80.2% | -21.5% | -6.7% | +13.1% | +21.4% | -11.5% | +32.5% | -34.6% | +5.2% | +3.0% | +13.9% | +1.2% | -56.0% | +5.0% | -20.8% | +41.6% | -20.8% | +35.8% | +2.7% | -26.5% | +2.1% | +18.3% | -13.3% | -4.1% | +10.8% | +27.9% | -25.2% | +213.8% | +52.9% | -19.2% | +6.4% | -9.7% | -55.4% | +89.7% | -28.2% | -68.4% | +214.7% | -29.4% | +11.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -832.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +151.4% | +70.9% | -26.9% | -89.7% | +169.6% | +253.2% | +78.1% | +31.3% | +17.4% | +71.1% | -6.1% | -13.0% | -2.1% | -5.2% | -62.0% | -61.8% | +851.8% | -93.8% | +9.0% | +4.1% | +1,156.6% | -87.7% | +232.3% | +129.7% | -20.9% | +144.5% | – | – | – | -100.0% | – | – | – | – | -8.8% | +18.8% | +176.6% | -83.8% | -1.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -899.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -26.9% | -199.1% | – | – | – | – | – | – | – | – | – | – | -111.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -899.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -740.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.